Home › Companies › Sanigen

Sanigen

세니젠 · 188260 · KOSDAQ
Filings, last 12 months
51
Supply contracts
0
Insider reports
6
Share & bond issues
3

At a glance

Sanigen filed 51 disclosures in the last 12 months, including 8 5% holder, 6 insider and 3 issuance. The most recent key filing was on Aug 21.

Revenue for 2025 was ₩15.4B, down 0.5% on 2024. It made an operating loss of ₩4.4B. Debt was 308% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩7.1B and operating loss of ₩1.3B.

The 2025 annual report lists 72 employees with an average tenure of 4.7 years and average pay of ₩55.7M, #1192 of 1,829 listed companies by average pay. Its 4 directors and auditors were paid ₩183M each on average. It paid no cash dividend for 2025. 박정웅 and related parties held 32.18% at year end.

From the 2025 annual report

Employees
72
Average pay
₩55.7M
Average tenure
4.7 yrs
Avg. director pay
₩183M

Staff: 72 (37 men, 35 women), of whom 1 on fixed-term contracts. Total pay for the year: ₩4B. Directors and auditors: 4, paid ₩730M in total.

No cash dividend was paid for 2025.

Largest shareholder

박정웅 holds 29.16%; with 8 related parties the group holds 32.18% of common shares at year end (from 31.90% at the start of the year).

Auditor: 한울회계법인 · opinion: Unqualified. The report includes an emphasis of matter.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

2023
Revenue ₩20.2B
Op. profit -₩6.5B
Debt/equity 57%
2024
Revenue ₩15.4B
Op. profit -₩5.9B
Debt/equity 78%
2025
Revenue ₩15.4B
Op. profit -₩4.4B
Debt/equity 308%
2026 H1
Revenue ₩7.1B
Op. profit -₩1.3B
Debt/equity 104%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

Other filings

Links open the original filing on DART, in Korean.